Kyropan-40
Your Guard Against Acid Peptic Disorders
Pantoprazole 40 mg tablets
Detailed Formulation & Active Ingredients
Each gastro-resistant tablet contains:
Pantoprazole Sodium Sesquihydrate equivalent to Pantoprazole 40 mg.
Therapeutic Indications & Clinical Scope
Duodenal ulcer, gastric ulcer, moderate to severe reflux esophagitis, Zollinger-Ellison syndrome, and prevention of NSAID-induced ulcers.
Dosage & Administration
One tablet daily morning before breakfast or as directed by physician.
Notice: Dosage schedules should be tailored according to clinical assessment and physician direction.
Storage & Handling Guidelines
Store in a dry place below 25°C. Protect from moisture and direct light.
Overview & Compliance
Kyropan-40 provides targeted gastric H+/K+-ATPase pump suppression. Its enteric-coated formulation ensures complete release in the intestine, offering rapid healing of mucosal damage and enduring acid control.
Inquire About Kyropan-40
Fill in the form below and our medical affairs representative will follow up with complete technical and supply details.
Other Formulations in Our Range
Tablets
IroK-XT
10x10 TabletsFerrous Ascorbate, Folic Acid & Zinc Sulphate Tablets
Tablets
Kyradox
10x10 TabletsDoxycycline 100 mg + Lactobacillus 60 mg
Tablets
Kyrocep-CV
10x10 TabletsCefpodoxime Proxetil 200 mg + Potassium Clavulanate 125 mg tablets